Regulatory conditions met for Novo Holdings' $16.5 billion Catalent deal, companies say By Reuters
(Reuters) - All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. drugmaker Catalent (NYSE:) have been ...
Tag: Catalent
Consumer groups ask FTC to block deal between Novo Holdings and Catalent By Reuters
By Jody Godoy and Maggie Fick NEW YORK (Reuters) - U.S. consumer groups and two major unions urged the U.S. ...
Catalent posts strong Q4 results, revenue up 23% year-over-year By Investing.com
NEW YORK – Catalent, Inc. (NYSE: NYSE:) on Thursday reported better-than-expected fourth-quarter results, with earnings and revenue beating analysts’ estimates ...
Danaher shows acquisition interest in contract manufacturer Catalent (NYSE:DHR)
Nastassia Samal Life sciences company Danaher Corporation (New York Stock Exchange:DHR) has expressed interest in acquiring contract manufacturer Catalent (NYSE:CTLT), ...
Recommended.
